Mode
Text Size
Log in / Sign up

Multicomponent breathing and exercise program improves breathlessness mastery in moderate to severe COPDNew Breathing Program Helps COPD Patients Regain Control Over Daily Life

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider this 8-week multicomponent program as a potential adjunct to improve breathlessness mastery in moderate to severe COPD.

This randomized controlled trial enrolled 113 patients with moderate to severe COPD (FEV1/forced vital capacity <0.70 and FEV1 ≤60% predicted) and disabling breathlessness (mMRC score ≥2) at the Westmead Breathlessness Service. Participants were assigned to an 8-week intervention involving breathing techniques, handheld fan use, exercise, energy conservation, and dietetic advice, or to an 8-week wait-list control group.

The primary outcome was change in the Chronic Respiratory Questionnaire (CRQ) Mastery of breathlessness subscale. The intervention group showed a clinically meaningful improvement, with an effect size of 0.5 units (95% CI 0.2 to 0.8; p=0.0262) compared to control. Secondary outcomes also improved: CRQ-Dyspnoea (0.4 units, 95% CI 0.1 to 0.7; p=0.005), CRQ-Fatigue (0.4 units, 95% CI 0.1 to 0.7; p=0.014), exertional breathlessness intensity (-0.8 units, 95% CI -1.4 to -0.2; p=0.013), and breathlessness unpleasantness (-1.2 units, 95% CI -1.7 to -0.6; p=0.001).

Safety and tolerability data were not reported. The study had an 8-week follow-up period. Key limitations include the lack of reported adverse events, the specific population (moderate to severe COPD with disabling breathlessness), and the setting at a single breathlessness service, which may limit generalizability.

Practice relevance is restrained; the intervention is non-pharmacologic and may be considered as an adjunct to standard care, but the evidence is from a single trial with short-term follow-up. Causality is supported by the randomized design, but the certainty is limited by the unreported safety data and single-center setting.

A simple coaching program teaches people with severe COPD how to manage breathlessness without relying only on medication.

Imagine walking from your bedroom to the kitchen and feeling like you just ran a race. For millions of people with COPD, this is a daily reality.

COPD, or chronic obstructive pulmonary disease, is a lung condition that makes it hard to breathe. It often gets worse over time. About 16 million Americans have it, and many more may be undiagnosed.

Current treatments include inhalers and oxygen therapy. But these don’t always solve the feeling of breathlessness that limits daily life. That’s where this new approach comes in.

The Old Way vs. The New Way

For years, doctors focused mainly on medication to treat COPD. Breathlessness was seen as just a symptom to manage with drugs.

But this study takes a different path. It focuses on teaching patients skills to manage their own breathing.

Here’s the twist: the program doesn’t use any new medicine. Instead, it uses coaching, breathing exercises, and simple lifestyle changes.

Think of breathlessness like a traffic jam. Your lungs are the road, and the air can’t move freely. Medication might clear one lane, but the jam still exists.

This program teaches drivers—patients—how to take side streets, leave earlier, and avoid rush hour. In other words, it gives them tools to work around the problem.

The program includes:

  • Breathing techniques to slow down air movement
  • Using a handheld fan to cool the face and reduce the urge to gasp
  • Gentle exercise to build stamina
  • Tips to save energy during daily tasks
  • Advice on eating well to maintain strength

These are simple strategies, but together they can make a big difference.

Researchers in Australia studied 113 people with moderate to severe COPD. All had significant breathlessness that limited their daily activities.

Half received the 8-week coaching program. The other half were placed on a waitlist and received usual care.

The study measured changes in how well patients controlled their breathlessness, their fatigue levels, and their emotional well-being.

Patients in the coaching group felt more in control of their breathing. On a standard breathing questionnaire, their scores improved by half a point more than the control group.

They also reported less breathlessness during daily activities. The intensity of their breathlessness dropped by nearly one full point on a 10-point scale.

Even the unpleasantness of breathlessness—how bad it felt—improved significantly.

Fatigue levels also went down. This is important because tiredness often goes hand-in-hand with breathlessness.

This doesn’t mean this treatment is available yet.

While the study is promising, experts caution that more research is needed. The program was tested in a controlled setting, and real-world results may vary.

Still, the approach aligns with growing interest in non-drug therapies for chronic disease. It empowers patients to take an active role in their care.

If you have COPD and struggle with breathlessness, talk to your doctor about non-drug strategies. Ask if there are breathing coaches or pulmonary rehab programs in your area.

This study shows that simple techniques can help, but they should be used alongside your current treatment plan—not as a replacement.

The study was small and lasted only 8 weeks. It’s unclear if the benefits last long-term.

Participants were mostly older adults in Australia, so results may not apply to everyone.

The program requires regular coaching, which may not be available in all areas.

Researchers plan to study whether these benefits last beyond 8 weeks. They also want to test the program in larger groups and in different countries.

If successful, this approach could become a standard part of COPD care. For now, it offers hope that simple skills can make daily life easier for those with severe COPD.

Study Details

Study typeRct
Sample sizen = 54
EvidenceLevel 2
Follow-up1.8 mo
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an often-progressive respiratory disease associated with disabling breathlessness. Breathlessness intervention services (BIS), which coach patients to self-manage breathlessness using non-pharmacological strategies, are effective in a variety of populations, including those with cancer and serious respiratory disease. This study aimed to compare the impact of the Westmead Breathlessness Service in people with moderate to severe COPD. METHODS: We analysed 113 participants randomised (1:1) with moderate/severe COPD (forced expiratory volume in 1 s (FEV)/forced vital capacity <0.70 and FEV ≤60% predicted) and disabling breathlessness (modified Medical Research Council (mMRC) Breathlessness Score ≥2) to either an 8-week intervention involving breathing techniques, handheld fan use, exercise, energy conservation, dietetic advice (n=54) or 8-week wait-list control group (n=59). The primary outcome was change in Chronic Respiratory Questionnaire (CRQ) Mastery of breathlessness subscale. Secondary outcomes included change in other CRQ subscales (Fatigue, Emotion and Dyspnoea), exertional breathlessness intensity/unpleasantness (0-10 Numerical Rating Scale Score), anxiety and depression. Difference in change over 8 weeks between groups was compared using ANCOVA; p<0.05 statistically significant. FINDINGS: Participants were aged 70.9 (±8.5) years, 50% female, mean FEV =0.8 L (±0.3 L; 34% predicted), mMRC Breathlessness Score 3 (IQR 3-4). CRQ-Mastery improved following intervention compared with control (between-group difference 0.5 units; 95% CI 0.2 to 0.8; p=0.0262) using modified intention-to-treat analysis. Better CRQ-Dyspnoea and CRQ-Fatigue were seen in the intervention group (between-group difference-CRQ-Dyspnoea 0.4 units; CI 0.1 to 0.7; p=0.005, and CRQ-Fatigue 0.4 units; CI 0.1 to 0.7; p=0.014). Exertional breathlessness intensity (difference -0.8 units; CI -1.4 to -0.2; p=0.013) and breathlessness unpleasantness (difference -1.2 units; CI -1.7 to -0.6; p=0.001) also improved. INTERPRETATION: An 8-week BIS improved CRQ-Mastery, Dyspnoea and Fatigue, exertional breathlessness intensity and unpleasantness in people with severe COPD.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.